|
시장보고서
상품코드
2077864
소아 완화 케어용 약물 시장 : 약제 클래스별, 투여 경로별, 유통 채널별, 지역별 - 규모, 점유율, 전망, 기회 분석(2025-2032년)Pediatric Palliative Care Drugs Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)Size, Share, Outlook, and Opportunity Analysis, 2025-2032 |
||||||
소아 완화 케어용 약물 시장은 2026년에 966억 5,000만 달러 규모에 이를 것으로 추정되고 있어 2033년까지 1,387억 5,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 5.3%로 성장할 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 966억 5,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 5.30% | 예측 금액(2033년) | 1,387억 5,000만 달러 |
소아 완화 케어란, 중증 질환을 앓고 있는 어린이들을 대상으로 하는 전문적인 의료 서비스를 말합니다. 완화 케어는 질병에 수반되는 증상과 스트레스를 완화하는 데 중점을 둡니다. 그 목적은 아동과 그 가족의 삶의 질(QOL)을 향상시키는 데 있습니다. 소아 완화 케어는 연령이나 질병의 진행 단계에 관계없이 언제든지 적절하게 이루어집니다. 신생아, 주산기 아동, 영아, 소아, 사춘기 아동, 청년에게 적합하며, 치료와 병행하여 제공할 수도 있습니다. 소아 완화 케어는 유전성 질환, 암, 조산, 신경계 질환, 심장 및 폐 질환 등 중증 질환을 대상으로 합니다. 통증, 숨가쁨, 피로, 변비, 메스꺼움, 식욕 부진, 불면증, 불안, 우울증 등의 증상을 완화합니다. 즉, 아이와 가족의 삶의 질을 높이는 데 도움이 됩니다. 소아 완화 케어는 생명을 위협하는 질환을 앓고 있는 아동과 그 가족의 삶의 질을 향상시키는 것을 목표로 하는 여러 전문직 간의 협력입니다. 세계보건기구(WHO)는 소아 완화 의료를 아동의 신체, 마음, 정신에 대한 적극적이고 종합적인 돌봄이며, 가족에 대한 지원도 포함하는 것으로 정의하고 있습니다. 완화 케어에서 가장 일반적으로 사용되는 약물로는 파라세타몰, 이부프로펜, 모르핀, 비사코딜, 메트로니다졸, 돈페리돈, 덱사메타손, 디아제팜 등이 있습니다. 또한 신부전, 근위축성 측삭 경화증(ALS), 암, 파킨슨병, 만성 폐쇄성 폐질환(COPD), 울혈성 심부전(CHF) 등의 만성 질환을 포함한 중증 질환의 치료에도 사용됩니다.
시장 역학
신제품 출시 증가와 주요 기업들의 합병 및 인수가 전 세계 소아 완화 케어용 약물 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2022년 4월 1일, 일본의 제약회사인 에자이 주식회사는 디지털 솔루션 사업의 기반을 강화하고 급속히 확장하기 위해, 일본의 의료용 블록체인 스타트업인 Arteryex Inc.를 인수한다고 발표했습니다. 양사는 협력하여 환자, 의료 종사자, 그리고 사회 전체를 대상으로 한 개인 건강 기록(PHR) 관련 서비스의 개발 및 제공에 힘써 나갈 것입니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장 성장 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 전 세계 소아 완화 케어용 약물 시장의 주요 기업 프로파일을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록했습니다.
- 본 보고서에서 다루고 있는 주요 기업으로는 Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co., Ltd., Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc., Eisai Inc. 등이 포함됩니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 소아 완화 케어용 약물 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 소아 완화 케어용 약물 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 소아 완화 케어용 약물 시장 : 약제 클래스별(2021-2033년)
제5장 세계의 소아 완화 케어용 약물 시장 : 투여 경로별(2021-2033년)
제6장 세계의 소아 완화 케어용 약물 시장 : 유통 채널별(2021-2033년)
제7장 세계의 소아 완화 케어용 약물 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
JHS 26.07.13Pediatric Palliative Care Drugs Market is estimated to be valued at USD 96.65 Bn in 2026 and is expected to reach USD 138.75 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 96.65 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.30% | 2033 Value Projection: | USD 138.75 Bn |
Pediatric palliative care is specialized medical care for children living with a serious illness. Palliative care focuses on providing relief from the symptoms and stress of the illness. The goal is to improve quality of life for both the child and the family. Pediatric palliative care is appropriate at any age and any stage of illness. It is appropriate for neonates, perinates, infants, children, adolescents, and young adults, and it can be provided along with treatment. Pediatric palliative care addresses serious medical conditions including genetic disorders, cancer, prematurity, neurologic disorders, heart and lung conditions, and others. It relieves the symptoms of these diseases such as pain, shortness of breath, fatigue, constipation, nausea, loss of appetite and difficulty sleeping, anxiety and depression. In short, it helps the child and the family improve their quality of life. Pediatric palliative care is an interdisciplinary collaboration that seeks to improve the quality of life for children with life-threatening conditions, as well as their families. The World Health Organization (WHO) defines pediatric palliative care as the active total care of the child's body, mind and spirit, which also involves giving support to the family. Different drugs most commonly used in palliative care are paracetamol, ibuprofen, morphine, bisacodyl, metronidazole, domperidone, dexamethasone, and diazepam. It is also used to treat serious disorders like chronic diseases such as kidney failure, Amyotrophic Lateral Sclerosis (ALS), cancer, Parkinson's disease, Chronic Obstructive Pulmonary Disease (COPD), and Congestive Heart Failure (CHF).
Market Dynamics
Increasing new product launches, and mergers and acquisitions by key market players are expected to drive the global pediatric palliative care drugs market growth. For instance, on April 1, 2022, Eisai Co., Ltd., a Japan-based pharmaceutical company announced the acquisition of Arteryex Inc., a Japan-based healthcare blockchain startup, to strengthen and rapidly expand the foundation of its digital solution business. The two companies will work together to develop and provide Personal Health Record (PHR)-related services for patients, healthcare professionals, and society at large.
Key features of the study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pediatric palliative care drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co.,Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pediatric palliative care drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric palliative care drugs market
Detailed Segmentation:
- Global Pediatric Palliative Care Drugs Market, By Drug Class (Revenue, USD Bn, 2021 - 2033)
- Analgesics
- Anti-emetics
- Laxatives
- Adjuvant Medications
- Steroids
- Sedatives
- Neuroleptic Medications
- Others
- Global Pediatric Palliative Care Drugs Market, By Route of Administration (Revenue, USD Bn, 2021 - 2033)
- Oral
- Topical
- Parenteral
- Global Pediatric Palliative Care Drugs Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Pediatric Palliative Care Drugs Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Novartis International AG
- Mylan NV
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Anqiu Lu'an Pharmaceutical Co., Ltd.
- Granules India Limited
- Zhejiang Kangle Pharmaceutical Co., Ltd.
- Farmson Pharmaceutical Gujarat Pvt. Ltd.
- Atabay Pharmaceutical Factory
- Anhui Fubore Pharmaceutical & Chemical Co., Ltd
- Huzhou Konch Pharmaceutical Co., Ltd.
- Alnylam Pharmaceuticals Inc.
- Eton Pharmaceuticals, Inc
- Eisai Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Pediatric Palliative Care Drugs Market, By Drug Class, 2021-2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Anti-emetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Adjuvant Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Steroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Sedatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Neuroleptic Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
5. Global Pediatric Palliative Care Drugs Market, By Route of Administration, 2021-2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
6. Global Pediatric Palliative Care Drugs Market, By Distribution Channel, 2021-2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
7. Global Pediatric Palliative Care Drugs Market , By Region, 2021-2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021-2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Novartis International AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan NV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amneal Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Anqiu Lu'an Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Granules India Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zhejiang Kangle Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Farmson Pharmaceutical Gujarat Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Atabay Pharmaceutical Factory
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Anhui Fubore Pharmaceutical & Chemical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Huzhou Konch Pharmaceutical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alnylam Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eton Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eisai Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
